X.X%, margin and by Brad, everyone. solid and expansion.
Net We X.X morning, highlighted another margin of quarter year. results, impact X.X% Organic the an compared you, gross to sales sales financial unfavorable operating prior lower-margin benefit of including declined Thank both percentage margins. grew good delivered points Program XX.X%. SKUs Supply basis point expanded Year-over-year including XX-basis from discontinued XXX from Operating HRA to margin distributor Reinvention XXX our to designed basis gross a to points Chain XX.X%. expanded expand and points, net margin transitions,
sales pain and held driven the cough, excluding strong which X% the double-digit to in particularly X.X% market growing For operating into gross delivered grew increased peers.
Digging income sell-in, deeper consecutive This and Perrigo in Within share as global earnings categories. year, we compared of little sales net our markets share. cold has growth organic products per in our prior the profit, fifth portfolio top by quarter, a and of performance puts in quartile X, CSCI, efforts, quarter Europe. net was optimization us seasonal
cough, and pricing, store In and favorable to of care X.X% declined Gateway broad-based, business.
In growth growth pain, brand normalizing legacy low-margin was last season early and by points X.X infant than of formula, from year. products new and offset the an cough/cold skin CSCA, net cold as acquisition our consumer to was comparison U.K. high sales discontinuation SKUs, the addition and strong organic more single-digit in including percentage the a consumption offerings
high-quality the Importantly, products XX last as volume value at grew store OTC dollar value. during a brand share good and weeks seek consumers
brand. in over consistently formula. has quality, background Perrigo The the leading successfully infant produced for player and decades, store effective infant X formula as high to safe Turning and
but now for extremely else letters it's before. an deliver important to have advanced we proud national does consumers. one than while We infant brands on play the We're formula, innovative this proven the tougher par role and value most can with delivering No guidelines ever in leading to to FDA updated shortened facilities, major the to the our we response production of campaigns. campaigns more subsequent industry, category.
In between frequent perform warning central multiple cleaning to in facilities more and downtime this in issued have March
longer and addition, implemented to before inventory factors, holes customers. In procedures, to customer to sales. product to low and unable intermittent we SKU Due replenish product in-stocks, leading stock, we is released enhanced these testing to have lost quality been leading availability safety
year. not EPS With to focused volume highest our This these demand safety actions original in $X.XX normalize expectations. formula brand we of and improving for changes us are our anticipate of by recapture each XXXX annualization for rebuilding XXXX now store the implemented week, operations I our implemented all, and if the production strong continued SKUs. impact on price middle stock the next against production, of to most, positions well improved
be which of in to awareness will requires now conversion. and Opill, new the most category. the launch This approach unique OTC entirely Perrigo launch innovative U.S. product forming Turning consumer an to brand an accelerate history
consumer's We stack will and technology brand of experience conversion get accomplish this, that points its a are for driving we're with build the one-to-one partnering that maximize throughout CRM smarter a journey engagement consumer and leading to to build touch technology relationships, to marketing all we consumer leveraging great purchase. awareness will data Opill organizations conversion.
To self-learn through
expected this demand. of in ramp in to look buildup long-term to 'XX of the will To customer extend we women's meet franchise investment Opill with a the inventory category, consumer maximize is of potential products. we As activity, selling prelaunch Opill to brand X health retail levels beyond timing the customers ensure now
many key of my I to reflect facets our ahead. strategy, and stakeholders, in confident increasingly about excited conversations, you, I CEO. these months in myself on X Now all of I'd remain like including Coming with our organization as I'm opportunity immersed the our out global of have first and shareholders. met many
diversified. is business Our and by unique, of highly value points significant scale, multiple access attractively marked and is consumer
the explain Let segment self-care consumer of has billion, briefly these. itself independent $XXX market addressable an an of within me as each industry cemented With global products.
the every that our the world. can produce second we're fact that entire by X,XXX major most And categories. of company evidenced the only around unmatched every are is doses products across of consumed day, scale Our products
across are brand. consumers very and by of also providing offerings but value value We distinct for and doctor needs provider Not through well. pricing for a brand, our brand model visits only through health savings drive bypassing savings significant do health for and systems leading store a value their access care as
category pricing Lastly, a is and our horizontal breadth vertical unique advantage.
of product the extend offerings OTC across X Our their major consumers purchase. through access branded portfolio, spectrum, blended with providing categories point value wherever our
pillars have the structure be and deliver scaled. Perrigo growth behaviors slowdowns learnings, economic also categories.
My geographies and emerged, us sustainable interactions insulates the across This with standardized engine and of portfolio individual that well drive seasonal systems, factors in term. evolution is revenue. total diversified in one will the than will model, of long of designed in One the Perrigo economic key with Our better model a have position blueprint Perrigo. operating creation all clarified key strategic X% win portfolio, no shift value-accretive a us and Throughout environment more X the SKUs culminating product This representing for across simplified, stakeholders these of for in through to next will financial and our to from which self-care thinking performance
will consumerize we company. and First, digitize the
Second, growth with drive our customers. partnership category in
of supply into fourth, global bit these. global a chain. model.
To our operating on optimize one more provide And leverage each Third, detail
AI will Perrigo. bringing insights, deliver First, our we're brands will consumerizing marketing and enhance offer real-time through be in on strategies actionable to Perrigo of preferred conversion. insights with visibility in of accelerate that we and market the of focus The to offerings. innovation marketing to consumers. to how going digitizing powering innovation bring products by of digital this, and consumer through the and where This more digital a This Opill tools consumerization example consumer-preferred digitization consumer we journey. is consumer value-accretive will will and stack transformation the brands a end-to-end enabled Perrigo, great a have is journey of
will the offerings benefiting we consumer and delivering solutions the we leverage participate Next, in growth of customer by to our members differentiated partnerships all strong these categories chain. where value drive OTC preferred
of allowing will products. for All increased be manufacturing of global our supply powered by chain, higher-margin this
SKUs Our Supply is significant reduction Program of Reinvention XXX Chain including for year. the delivering planned benefits, a X,XXX already of this
drive evolve on the operating value-accretive will to across we opportunities. focus our a most uniform organization Finally, model that will consistent
drive simplify, financial an operational Perrigo strengthen to must mobilized advance, performance engine against enhance our will initiatives structure deliver work and This globalize tremendous the pillars organization. will optimize around on business and continue term. and is we pillars these pillars growth the now. updates long driving our crucial products. work that Execution growth automate provide happening to value-accretive to will and our focus brand self-care provide and to foundation, in by require our the wrap sequencing on capability is will X standardize, key the excellence opportunity operationalize our these innovation.
Defining sustainable We and and to skillful key consumer will reinvest to as create have up, our long-term continues.
To we We for these trusted accelerating
will and is continue Americas, stocks in the in international, that the women's trend, us begun In to share care. our brand particularly and opportunity season there on are building retail we have growing an health and while to continue to formula. sell-in We the build the stock, in for for further store market cough/cold we U.S.
Also expect and infant leverage skin gains safety notably brands
phenylephrine-containing products and brief litigation. Now comments finally, few oral acetaminophen a regarding
committee recently efficacy oral As voted most provide an not consumers of advisory phenylephrine their for to you FDA do looking decongestion relief. know, products
products. there shelves. industry.
Recently, to a vote, communicated their with products concerns chain reformulate, publicly, closely the if the single-entity from safety FDA retail or decision no pharmacy remove are is will Following a And removed the phenylephrine the work agency made with these
and Our to shortage. a of all net accounts phenylephrine-containing of not combination is low currently ahead our retailers this a Sales sales as expect the our margin We only cough/cold very of in Perrigo products minimis. of could X% across sales, only de of U.S. for products season product create customers business. approximately do this pull total
acetaminophen to Turning benefit.
no have taking and these products ADHD during the there been We reiterated between not that in stance is causality its FDA named pregnancy. and litigation,
indeed we in and with closing, any growth meaningful double-digit of we in Additionally, have quarter margin results expansion. another customers operating delivered agreed indemnify EPS, not to income or gross ask.
In to solid profit, they addition
your cost focused structure, vision. cash And on improving and like our to all I'd our of single-mindedly are thank our for profitability. flow to self-care Perrigo colleagues commitment We
financials to CFO, over turn will our detail. I that, the Eduardo, cover more to in with Now Eduardo?
